Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income $ 16,404 $ 11,911
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 8,571 4,729
Loss on disposal of assets 71  
Stock-based compensation expense 1,368 916
Amortization of debt issuance costs 179 98
(Benefit) provision for deferred income taxes (322) 55
Change in fair value of contingent consideration 719 402
Forward contract losses, net 24 505
Other, net 549 (15)
(Increase) decrease in:    
Accounts receivable (8,848) (9,683)
Inventories (3,729) 940
Other current assets (2,455) (219)
Other assets 1,088 (251)
Increase (decrease) in:    
Accounts payable 662 1,114
Accrued expenses and other liabilities 3,496 1,469
Income taxes payable 2,710 2,671
Other noncurrent liabilities (659) 17
Net cash provided by operating activities 19,828 14,659
Cash flows from investing activities:    
Capital expenditures (8,792) (4,237)
Proceeds from dispositions of equipment 64 3
Net cash used in investing activities (8,728) (4,234)
Cash flows from financing activities:    
Borrowings on revolving credit facility 35,282  
Repayment of borrowings on revolving credit facility (48,000) (116,000)
Borrowings on long-term non-revolving debt   932
Repayment of borrowings on long-term non-revolving debt (1,623)  
Proceeds from stock issued 408 240,163
Dividends to shareholders (2,878) (2,437)
Other financing activities (881) (240)
Net cash (used in) provided by financing activities (17,692) 122,418
Effect of exchange rate changes on cash, cash equivalents and restricted cash (167) 1,805
Net (decrease) increase in cash, cash equivalents and restricted cash (6,759) 134,648
Cash, cash equivalents and restricted cash, beginning of period 23,515 63,922
Cash, cash equivalents and restricted cash, end of period $ 16,756 $ 198,570